BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35052701)

  • 21. Musashi-1 promotes chemoresistant granule formation by PKR/eIF2α signalling cascade in refractory glioblastoma.
    Chen HY; Lin LT; Wang ML; Tsai KL; Huang PI; Yang YP; Lee YY; Chen YW; Lo WL; Lan YT; Chiou SH; Lin CM; Ma HI; Chen MT
    Biochim Biophys Acta Mol Basis Dis; 2018 May; 1864(5 Pt A):1850-1861. PubMed ID: 29486283
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of Dysregulated microRNAs in Glioblastoma Stem-like Cells.
    Evers L; Schäfer A; Pini R; Zhao K; Stei S; Nimsky C; Bartsch JW
    Brain Sci; 2023 Feb; 13(2):. PubMed ID: 36831894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. MiR-7-5p suppresses stemness and enhances temozolomide sensitivity of drug-resistant glioblastoma cells by targeting Yin Yang 1.
    Jia B; Liu W; Gu J; Wang J; Lv W; Zhang W; Hao Q; Pang Z; Mu N; Zhang W; Guo Q
    Exp Cell Res; 2019 Feb; 375(1):73-81. PubMed ID: 30586549
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MicroRNA-106a-5p facilitates human glioblastoma cell proliferation and invasion by targeting adenomatosis polyposis coli protein.
    Li D; Wang Z; Chen Z; Lin L; Wang Y; Sailike D; Luo K; Du G; Xiang X; Jiafu GD
    Biochem Biophys Res Commun; 2016 Dec; 481(3-4):245-250. PubMed ID: 27815074
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The lncRNA RP3-439F8.1 promotes GBM cell proliferation and progression by sponging miR-139-5p to upregulate NR5A2.
    Qi J; Pan L; Yu Z; Ni W
    Pathol Res Pract; 2021 Jul; 223():153319. PubMed ID: 33991848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. miR-6858 plays a key role in the process of melatonin inhibition of the malignant biological behavior of glioma.
    Wang C; Zhao Z; Qi Q; Wang J; Kong Y; Feng Z; Chen A; Li W; Zhang Q; Wang J; Huang B; Li X
    J Clin Neurosci; 2021 May; 87():137-146. PubMed ID: 33863521
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Musashi-1 Regulates MIF1-Mediated M2 Macrophage Polarization in Promoting Glioblastoma Progression.
    Yang YP; Chien CS; Yarmishyn AA; Chan MS; Lee AC; Chen YW; Huang PI; Ma HI; Lo WL; Chien Y; Lin WC; Wang ML; Chen MT
    Cancers (Basel); 2021 Apr; 13(8):. PubMed ID: 33918794
    [TBL] [Abstract][Full Text] [Related]  

  • 28. LncRNA MIR4435-2HG potentiates the proliferation and invasion of glioblastoma cells via modulating miR-1224-5p/TGFBR2 axis.
    Xu H; Zhang B; Yang Y; Li Z; Zhao P; Wu W; Zhang H; Mao J
    J Cell Mol Med; 2020 Jun; 24(11):6362-6372. PubMed ID: 32319715
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CircFOXO3 promotes glioblastoma progression by acting as a competing endogenous RNA for NFAT5.
    Zhang S; Liao K; Miao Z; Wang Q; Miao Y; Guo Z; Qiu Y; Chen B; Ren L; Wei Z; Lin Y; Lu X; Qiu Y
    Neuro Oncol; 2019 Oct; 21(10):1284-1296. PubMed ID: 31504797
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long noncoding RNA-RNCR3 overexpression deleteriously affects the growth of glioblastoma cells through miR-185-5p/Krüppel-like factor 16 axis.
    Zhang L; Cao Y; Wei M; Jiang X; Jia D
    J Cell Biochem; 2018 Nov; 119(11):9081-9089. PubMed ID: 29953649
    [TBL] [Abstract][Full Text] [Related]  

  • 31. miR-425-5p, a SOX2 target, regulates the expression of FOXJ3 and RAB31 and promotes the survival of GSCs.
    de la Rocha AMA; González-Huarriz M; Guruceaga E; Mihelson N; Tejada-Solís S; Díez-Valle R; Martínez-Vélez N; Fueyo J; Gomez-Manzano C; Alonso MM; Laterra J; López-Bertoni H
    Arch Clin Biomed Res; 2020; 4(3):221-238. PubMed ID: 32905473
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MSI1 Promotes the Expression of the GBM Stem Cell Marker CD44 by Impairing miRNA-Dependent Degradation.
    Pötschke R; Haase J; Glaß M; Simmermacher S; Misiak C; Penalva LOF; Kühnöl CD; Hüttelmaier S
    Cancers (Basel); 2020 Dec; 12(12):. PubMed ID: 33291443
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-135b contributes to the radioresistance by targeting GSK3β in human glioblastoma multiforme cells.
    Xiao S; Yang Z; Lv R; Zhao J; Wu M; Liao Y; Liu Q
    PLoS One; 2014; 9(9):e108810. PubMed ID: 25265336
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Gelsolin inhibits malignant phenotype of glioblastoma and is regulated by miR-654-5p and miR-450b-5p.
    Zhang J; Furuta T; Sabit H; Tamai S; Jiapaer S; Dong Y; Kinoshita M; Uchida Y; Ohtsuki S; Terasaki T; Zhao S; Nakada M
    Cancer Sci; 2020 Jul; 111(7):2413-2422. PubMed ID: 32324311
    [TBL] [Abstract][Full Text] [Related]  

  • 35. LINC01579 promotes cell proliferation by acting as a ceRNA of miR-139-5p to upregulate EIF4G2 expression in glioblastoma.
    Chai Y; Xie M
    J Cell Physiol; 2019 Dec; 234(12):23658-23666. PubMed ID: 31187495
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hypoxic signature of microRNAs in glioblastoma: insights from small RNA deep sequencing.
    Agrawal R; Pandey P; Jha P; Dwivedi V; Sarkar C; Kulshreshtha R
    BMC Genomics; 2014 Aug; 15(1):686. PubMed ID: 25129238
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNA-193a-5p exerts a tumor suppressor role in glioblastoma via modulating NOVA1.
    Jin L; Li H; Wang J; Lin D; Yin K; Lin L; Lin Z; Lin G; Wang H; Ying X; Wang L; Zhang Y; Teng L
    J Cell Biochem; 2019 Apr; 120(4):6188-6197. PubMed ID: 30304561
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Circ-0001801 contributes to cell proliferation, migration, invasion and epithelial to mesenchymal transition (EMT) in glioblastoma by regulating miR-628-5p/HMGB3 axis.
    Chen WL; Jiang L; Wang JS; Liao CX
    Eur Rev Med Pharmacol Sci; 2019 Dec; 23(24):10874-10885. PubMed ID: 31858556
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA-744-5p inhibits glioblastoma malignancy by suppressing replication factor C subunit 2.
    Fan F; Yao D; Yan P; Jiang X; Hu J
    Oncol Lett; 2021 Aug; 22(2):608. PubMed ID: 34188710
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The miR155HG/miR-185/ANXA2 loop contributes to glioblastoma growth and progression.
    Wu W; Yu T; Wu Y; Tian W; Zhang J; Wang Y
    J Exp Clin Cancer Res; 2019 Mar; 38(1):133. PubMed ID: 30898167
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.